Cellmid Ltd (CDY) - Medical Equipment - Deals and Alliances Profile
December 2018
33
About the Report
About the Report
Summary
Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such as midkine ELISA kit, advangen international hair loss products and evolis products. Cellmid develops CAB102, a humanized monoclonal antibody for use in solid tumors; CAB101, a monoclonal antibody for the treatment of kidney injury, and inflammatory and fibrotic diseases; and CMK103, a recombinant human form of MK protein for use in cardiac ischemia. The company markets its products in Australia and Japan. Cellmid is headquartered in Sydney, New South Wales, Australia.
Cellmid Ltd (CDY)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Cellmid Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cellmid Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cellmid Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cellmid Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cellmid Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cellmid Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cellmid Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Fujikura Kasei Exercises Option For Licensing Agreement With Cellmid For Anti-Midkine Diagnostic Antibodies 10
Equity Offering 11
Cellmid Raises USD0.7 Million in Share Purchase Plan of Shares 11
Cellmid Raises USD1.3 Million in First Tranche of Private Placement of Shares 12
Cellmid to Raise USD5.4 Million in Second Tranche of Private Placement of Shares 13
Cellmid to Raise USD0.8 Million in Private Placement of Shares 14
Cellmid Raises USD3.19 Million in Private Placement of Shares 15
Cellmid Raises USD2.4 Million in First Tranche of Private Placement of Shares 16
Cellmid Completes Private Placement Of Shares For USD 1.8 Million 17
Cellmid Completes Private Placement Of Shares For USD 2 Million 18
Cellmid Completes Private Placement Of Shares For USD 0.3 Million 19
Cellmid Ltd-Key Competitors 20
Cellmid Ltd-Key Employees 21
Cellmid Ltd-Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Jul 31, 2018: Cellmid notes to the appendix 4c-growing consumer health sales drive revenue uplift 23
Sep 27, 2017: Cellmid's FY2017 Results Presentation 25
Corporate Communications 26
Oct 16, 2017: Cellmid Appoints Dr Martin Cross as Non-executive Director 26
Legal and Regulatory 27
Nov 02, 2018: Ikon legal action-decision handed down 27
May 29, 2018: Cellmid announces Change of Address 28
Product News 29
May 30, 2018: 5th Midkine Symposium Reinforces Clinical Potential For Cellmid'S Biotechnology Assets 29
Other Significant Developments 31
Jan 09, 2018: Cellmid Quarterly Operational Update 31
Oct 25, 2017: Cellmid: Notes to the Appendix 4C 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33
List of Figure
List of Figures
Cellmid Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cellmid Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cellmid Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cellmid Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cellmid Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cellmid Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cellmid Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cellmid Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List of Table
List of Tables
Cellmid Ltd, Medical Equipment, Key Facts, 2018 2
Cellmid Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cellmid Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cellmid Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cellmid Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cellmid Ltd, Deals By Market, 2012 to YTD 2018 8
Cellmid Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Fujikura Kasei Exercises Option For Licensing Agreement With Cellmid For Anti-Midkine Diagnostic Antibodies 10
Cellmid Raises USD0.7 Million in Share Purchase Plan of Shares 11
Cellmid Raises USD1.3 Million in First Tranche of Private Placement of Shares 12
Cellmid to Raise USD5.4 Million in Second Tranche of Private Placement of Shares 13
Cellmid to Raise USD0.8 Million in Private Placement of Shares 14
Cellmid Raises USD3.19 Million in Private Placement of Shares 15
Cellmid Raises USD2.4 Million in First Tranche of Private Placement of Shares 16
Cellmid Completes Private Placement Of Shares For USD 1.8 Million 17
Cellmid Completes Private Placement Of Shares For USD 2 Million 18
Cellmid Completes Private Placement Of Shares For USD 0.3 Million 19
Cellmid Ltd, Key Competitors 20
Cellmid Ltd, Key Employees 21
Cellmid Ltd, Subsidiaries 22
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.